Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 305, Issue 1, 2003, Pages 385-393

  Inoue, Koki ^a,b   Valdez, Glenn R ^a   Reyes, Teresa M ^c   Reinhardt, Lindsay E ^a   Tabarin, Antoine ^a,d   Rivier, Jean ^c   Vale, Wylie W ^c   Sawchenko, Paul E ^c   Koob, George F ^a   Zorrilla, Eric P ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^d UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR; UROCORTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; FEEDING BEHAVIOR; FOOD ANALYSIS; IMMUNOHISTOCHEMISTRY; LIGHT DARK CYCLE; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; TASK PERFORMANCE; TASTE AVERSION;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; EATING; HUMANS; MALE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; WATER;

EID: 0037379963     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.047712     Document Type: Article

References (42)

1. Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW, and Lee KF (2000) Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24:410-414.
2. Benoit SC, Schwartz MW, Lachey JL, Hagan MM, Rushing PA, Blake KA, Yagaloff KA, Kurylko G, Franco L, Danhoo W, and Seeley RJ (2000) A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences. J Neurosci 20:3442-3448.
3. Bittencourt JC and Sawchenko PE (2000) Do centrally administered neuropeptides access cognate receptors? An analysis in the central corticotropin-releasing factor system. J Neurosci 20:1142-1156.
4. Blundell JE (1986) Serotonin manipulations and the structure of feeding behaviour. Appetite 7:39-56.
5. Blundell JE and Latham CJ (1978) Pharmacological manipulation of feeding behavior: possible influences of serotonin and dopamine on food intake, in Central Mechanisms of Anorectic Drugs (Garattini S and Samanin R, eds), pp 83-109, Raven Press, New York.
6. Bradbury MJ, McBurnie MI, Denton DA, Lee KF, and Vale WW (2000) Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice. Endocrinology 141:2715-2724.
7. Burton MJ, Cooper SJ, and Popplewell DA (1981) The effect of fenfluramine on the microstructure of feeding and drinking in the rat. Br J Pharmacol 72:621-633.
8. Chan RKW and Sawchenko PE (1994) Spatially and temporally differentiated patterns of c-fos expression in brainstem catecholaminergic cell groups induced by cardiovascular changes in the rat. J Comp Neurol 348:433-460.
9. Contarino A, Dellu F, Koob GF, Smith GW, Lee KF, Vale WW, and Gold LH (2000) Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice. Endocrinology 141:2698-2702.
10. Cooper SJ, Francis J, and Rusk IN (1990) The anorectic effect of SK&F 38393, a selective dopamine D1 receptor agonist: a microstructural analysis of feeding and related behaviour. Psychopharmacology 100:182-187.
11. Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR, et al. (2000) Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 24:403-409.
12. Day HE, McKnight AT, Poat JA, and Hughes J (1994) Evidence that cholecystokinin induces immediate early gene expression in the brainstem, hypothalamus and amygdala of the rat by a CCKA receptor mechanism. Neuropharmacology 33:719-727.
13. Dess NK and Vanderweele DA (1994) Lithium chloride and inescapable, unsignaled tail shock differentially affect meal patterns of rats. Physiol Behav 56:203-207.
14. Grinker JA, Drewnowski A, Enns M, and Kissileff H (1980) Effects of d-amphetamine and fenfluramine on feeding pattens and activity of obese and lean Zucker rats. Pharmacol Biochem Behav 12:265-275.
15. Grote FW and Brown RT (1971) Conditioned taste aversion: two-stimulus tests are more sensitive than one-stimulus tests. Behav Res Methods Instrum 3:311-312.
16. Heinrichs SC, Britton KT, and Koob GF (1991) Both conditioned taste preference and aversion induced by corticotropin-releasing factor. Pharmacol Biochem Behav 40:717-721.
17. Hsu SY and Hsueh AJ (2001) Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7:605-611.
18. Kaplan JM, Donahey J, Baird JP, Simansky KJ, and Grill HJ (1997) d-Fenfluramine anorexia: dissociation of ingestion rate, meal duration and meal size effects. Pharmacol Biochem Behav 57:223-229.
19. Koob GF and Heinrichs SC (1999) A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res 848:141-152.
20. Koob GF, Heinrichs SC, Menzaghi F, Pich EM, and Britton KT (1994) Corticotropin releasing factor, stress and behavior. Semin Neurosci 6:221-229.
21. Langhans W, Grossmann F, and Geary N (2001) Intrameal hepatic-portal infusion of glucose reduces spontaneous meal size in rats. Physiol Behav 73:499-507.
22. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, et al. (2001) Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 98:7570-7575.
23. Li BH and Rowland NE (1993) Dexfenfluramine induces Fos-like immunoreactivity in discrete brain regions in rats. Brain Res Bull 31:43-48.
24. Li H-Y and Sawchenko PE (1998) Hypothalamic effector neurons and extended circuitries activated in "neurogenic" stress: a comparison of footshock effects exerted acutely, chronically and in animals with controlled glucocorticoid levels. J Comp Neurol 393:244-266.
25. Million M, Maillot C, Saunders P, Rivier J, Vale W, and Tache Y (2002) Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats. Am J Physiol Gastrointest Liver Physiol 282:G34-40.
26. Pellegrino LJ, Pellegrino AS, and Cushman AJ (1979) A Stereotaxic Atlas of the Rat Brain, Plenum, New York.
27. Pelleymounter MA, Joppa M, Carmouche M, Cullen MJ, Brown B, Murphy B, Grigoriadis DE, Ling N, and Foster AC (2000) Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF. J Pharmacol Exp Ther 293:799-806.
28. Perrin MH and Vale WW (1999) Corticotropin releasing factor receptors and their ligand family. Ann N Y Acad Sci 885:312-328.
29. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW and Sawchenko PE (2001) Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98:2843-2848.
30. Ritter RC, Covasa M, and Matson CA (1999) Cholecystokinin: proofs and prospects for involvement in control of food intake and body weight. Neuropeptides 33:387-399.
31. Sakai N and Yamamoto T (1997) Conditioned taste aversion and c-fos expression in the rat brainstem after administration of various USs. Neuroreport 8:2215-2220.
32. Seeley RJ, Blake K, Rushing PA, Benoit S, Eng J, Woods SC, and D'Alessio D (2000) The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride. J Neurosci 20:1616-1621.
33. Spina M, Merlo-Pich E, Chan RK, Basso AM, Rivier J, Vale W, and Koob GF (1996) Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science (Wash DC) 273:1561-1564.
34. Takeda N, Hasegawa S, Morita M, and Matsunaga T (1993) Pica in rats is analogous to emesis: an animal model in emesis research. Pharmacol Biochem Behav 45: 817-821.
35. Tarjan E, Denton DA, and Weisinger RS (1991) Corticotropin-releasing factor enhances sodium and water intake/excretion in rabbits. Brain Res 542:219-224.
36. Thiele TE, van Dijk G, Yagaloff KA, Fisher SL, Schwartz M, Burn P, and Seeley RJ (1998) Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion. Am J Physiol 274:R248-254.
37. Valdez GR, Inoue K, Koob GF, Rivier J, Vale W, and Zorrilla EP (2002) Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide. Brain Res 943:142-150.
38. Van Dijk G, Thiele TE, Donahey JC, Campfield LA, Smith FJ, Burn P, Bernstein IL, Woods SC, and Seeley RJ (1996) Central infusions of leptin and GLP-1-(7-36) amide differentially stimulate c-FLI in the rat brain. Am J Physiol 271:R1096-1100.
39. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W, and Sawchenko PE (2000) Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428:191-212.
40. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, et al. (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing corticotropin-releasing factor. Nature (Lond) 378:287-292.
41. Weisinger RS, Blair-West JR, Burns P, Denton DA, McKinley MJ, Purcell B, Vale W, Rivier J, and Sunagawa K (2000) The inhibitory effect of hormones associated with stress on Na appetite of sheep. Proc Natl Acad Sci USA 97:2922-2927.
42. West DB, Greenwood MR, Marshall KA, and Woods SC (1987) Lithium chloride, cholecystokinin and meal patterns: evidence that cholecystokinin suppresses meal size in rats without causing malaise. Appetite 8:221-227.